Effective testosterone suppression for patients with prostate cancer: is there a best castration?
Oefelein
Michael G
MG
Department of Urology, Case Western Reserve University, University Hospitals of Cleveland, Cleveland, Ohio 44106, USA.
Resnick
Martin I
MI
D000726:Androgen Antagonists / Q000191:economics / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009919:Orchiectomy / Q000379:methods*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013739:Testosterone / Q000037:antagonists & inhibitors*
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D013739:Testosterone